Novartis Man succeeds Implenia Primal Affentranger



[ad_1]

The change of leadership is not a surprise. Affentranger has already announced early 2016 that he wants to resign in two years at the head of Implenia. The board of directors therefore looked for a successor some time ago, as Implenia announced Wednesday.

The new Wyss CEO has decades of international leadership experience in various roles. Until spring 2018, he was a member of the Novartis Executive Committee. There, the 51-year-old Swiss manages the entire production of Novartis, the central business and corporate affairs department, with nearly 40,000 employees worldwide. At the same time, he was president of Novartis Switzerland

. When Wyss takes up his new job in the construction business on October 1, he follows in his footsteps. His predecessor Anton Affentranger has characterized the construction business since its appearance in 2006 as no one else. Zschokke's then president, Mr Affentranger, was not only the architect of the merger of the Geneva construction giant with Basler's Bati group. He has also shown a lot of creative will and has been the strong and decisive figure of the company.

Implentranger led Implenia to size

Under his leadership, Implenia grew from 2 to 4 billion francs in turnover. In addition, under his aegis, the expansion abroad was encouraged. He also avoided the construction company from embarking on a defensive battle against the Laxey hedge fund. The activist investor Laxey wanted to conquer the construction business in 2009 and sell it in spare parts. The chairman of the board of directors, Hans Ulrich Meister, thanked the Affentranger Communiqué for his many years of fruitful work

However, the era of Affentranger was not only glorious and successful at Implenia . Affentranger has repeatedly proven his only claim to leadership in the business. In 2009, in his capacity as Chairman of the Board of Directors, he also assumed the role of CEO in an emergency exercise. Trigger was a sparkle. After the resignation of Christian Bubb, longtime boss of Zschokke and Implenia, in 2009, his successor Werner Karlen only held two months in the construction business.

Hans Peter Fässler, replaced by Affentranger after disappointing semester figures at the end of 2011, the distance. Subsequently, Affentranger took over the position, but abandoned the position of chairman of the board. This apparently without losing its decisive position in the company, as was clear in February 2016 at the latest. Hubert Achermann, President of Implenia, resigns immediately. Reason was according to media reports a power struggle lost with Affentranger. Achermann should have tried to prevent it.

Beginning of a new era

Affentranger announced at the time that he also only wanted to remain as the boss of Implenia for about two years. With a little delay, he has now bought this ad. Affentranger completely leaves the company. A return of Implenia's Board of Directors is neither planned nor planned, according to the spokesperson of Implenia Urs Knapp at the request of AWP

The Board of Directors Administration does not meet the wishes of the successor in the appointment of his successor. Still-Implenia Chefs is consistent. He hopes that an internal succession solution will be found, said Mr. Affentranger in the spring of 2016. With André Wyss now an external and especially non-sectoral position occupying his position.

Implenia's share on Wednesday in a slightly turbulent global market lost 3.2% to 73.45 francs. So it was a real change of leadership, said the ZKB in a comment. With André Wyss, a high-level successor with international leadership experience was found.

lie / cf

(AWP)

[ad_2]
Source link